Good prescribing: better systems and prescribers needed
- Conscience vs. patient rights. Ukens, Carol // Drug Topics;5/19/97, Vol. 141 Issue 10, p38
Reports on a controversy over pharmacists' right to conscientious objection versus their duty to patients when they refuse to dispense certain medications. Policy by Longs Drug Store regarding a pharmacist's refusal to fill a prescription; Comment of the California Pharmacists Association on...
- Prescriber Profiles. Capozzi, James D.; Rhodes, Rosamond // Journal of Bone & Joint Surgery, American Volume;Jul2001, Vol. 83-A Issue 7, p1115
Within a two-week period, two sales representatives from competing pharmaceutical companies visited the office of an orthopaedic group practice. One representative was elated that the group had been steadily prescribing his company's new arthritis medication. The physicians assumed that the...
- What changes can we expect? Neugebauer, Roger; Donohue, Chip; Schweinhart, Larry; Milic, Sasa; Martin, Jody // Exchange (19460406);Jul/Aug2011, Issue 200, p84
The article presents a reprint of the article "What changes can we expect?" by Roger Neugebauer, Chip Donohue and Larry Schweinhart which appeared in the previous issue of "Exchange" magazine. It provides a forecast on early childhood education in the U.S. It mentions that the potential change...
- `No' to title. Conlan, Michael F. // Drug Topics;9/4/95, Vol. 139 Issue 17, p12
Reports on issues discussed at the 1995 congress of the American College of Clinical Pharmacy. Certification of pharmacists in general practice; Prescriptive authority of pharmacists.
- In a break from the past, clinical R.Ph. group goes to Washington. Chi, Judi // Drug Topics;11/20/2000, Vol. 114 Issue 22, p29
Highlights the plans of the American College of Clinical Pharmacy (ACCP) for its third decade of operation beginning in 2000. Expansion of the association's personnel; Establishment of a Washington, D.C. office; Goals of ACCP.
- Lifestyle drugs: issues for debate. Lexchin, Joel // CMAJ: Canadian Medical Association Journal;5/15/2001, Vol. 164 Issue 10, p1449
Comments on 'lifestyle' drugs and the issues which they have raised for physicians, for the health care system in terms of priorities for drug expenditures, and for society in general. Challenge in defining lifestyle drugs; Consideration of where to draw the line between social and medical...
- Two views on funding. Romano, Michael // Modern Healthcare;04/23/2001, Vol. 31 Issue 17, p12
Discusses the alliance between the American Medical Association (AMA) and Eli Lilly and Co. to launch an educational campaign on physician prescribing practices. Discussion on the ethical aspect of the partnership; Views of several physicians on the issue; Information on the task force formed...
- OK to give PDE-5 Rx for pleasure only? Opinion split. Binder, Stefanie Petrou // Urology Times;Jun2012, Vol. 40 Issue 7, p34
The article reports on the results of a survey led by Dr. Ilan Gruenwald of Rambam Healthcare Campus in Haifa, Israel that showed that physician opinion is divided over the prescription of phosphodiesterase type-5 (PDE-5) inhibitors to men without erectile dysfunction (ED) for non-medical...
- Call for rapid reduction in number of people on antipsychotic medication. // Learning Disability Practice;Sep2015, Vol. 18 Issue 7, p6
The article reports that the National Health Service (NHS) England has promised to reduce the overprescribing of antipsychotics among patients with learning disabilities, following revelation that 73% of learning disabled inpatients received such medications.